Neumann Clarke

Sequenom Inc.

VP & General Counsel

Avg. Two Year Performance

19% Avg. Purchase Return 9% Compound

47% Avg. Sale Return 21% Compound

Holdings: 21.91K shares

Last Three Months: 27-Aug-24 -- 26-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

27-Nov-22 -- 26-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions